The Zhitong Finance App learned that the 16th International Conference on Reproductive Immunology (ISIR 2026) will be held in Busan, South Korea from November 5 to 8, 2026. The Shenzhen Zhongshan Obstetrics and Gynecology Hospital team, a subsidiary of Jinxin Reproduction (01951), shared research progress and experience with international peers on repeated embryo implantation failures, euploid abortions, and fertility difficulties related to autoimmunity through 4 academic reports and 1 poster. Team member Yu Shuyi won the Young Scholar Clinical Research Award at this conference.
Dr. Diao Lianghui, Director of Jinxin Medical Science and Technology Innovation Center and Director of the Clinical Research Center of Shenzhen Zhongshan Obstetrics and Gynecology Hospital, was invited to give a special presentation and co-hosted a special session on “Immune Regulation and Treatment Applications in Human Reproduction” on November 8. Diao Lianghui also served as a member of the scientific committee of this conference.
Picture: “Jinxin Team” team members
For families that have gone through many treatments and still haven't met their wishes, it is a matter of concern to further search for the cause, understand the test results, and determine the basis for the next step. On November 6, in the report “How Endometrial Inflammation and Immune Remodeling Influence Bed and Early Pregnancy”, Diao Lianghui discussed the relationship between changes in endometrial immunity and embryo implantation and early pregnancy in combination with testing methods established by the team, normal endometrial references and clinical studies, and responded to the important question of how to evaluate and explain endometrial abnormalities in clinical practice.
The team's other reports also closely address clinical challenges. Li Yuye is concerned about the difficulties women may still face in assisted reproduction during the remission phase of systemic lupus erythematosus; Yang Lingtao introduced the endometrial immune map and the relationship between “lymphocyte aggregates” and adverse pregnancy outcomes; Yu Shuyi, who was selected by the hospital to study for a doctorate degree at the Chinese University of Hong Kong, shared collaborative research on the characteristics of endometrial immunity and the risk of euploid abortion during the Young Scholar Award competition. Hong Ling, on the other hand, introduced experimental studies on the effects of glutamine on macrophage function and endometrial decidualization through a poster.
Photo: Group photo of team member Yu Shuyi and Award Committee Chairman Udo Markert
These tasks are carried out by the hospital's reproductive immunization clinical team and full-time researchers to link problems encountered in diagnosis and treatment with clinical samples, pregnancy follow-up, and experimental research. This year, the relevant endometrial immunogram study was published in “Nature Communications” (Nature Communications), and Shenzhen Zhongshan Obstetrics and Gynecology Hospital was the first signatory unit and first corresponding author unit. At the beginning of the year, Diao Lianghui and Li Yuye also participated in the formulation of the 2026 “International Expert Consensus on Chronic Endometritis” as members of the international expert team.
Relying on platforms such as the Clinical Research Center and the Shenzhen Key Laboratory of Periimplantation Reproductive Immunity, Zhongshan, Shenzhen continues to carry out domestic and international cooperative research and the training of young talents. This international academic exchange showcased the team's expertise in the field of reproductive immunization. It also showed that Jinxin Reproductive Hospitals use scientific research to support clinical practice and continuously improve their professional service capabilities.